GNPG, WLSI, IGSM, XMDC, DRGZ, OOIL OTCPicks.com Stocks to Watch for Tuesday, October 27th

Our Stocks to Watch tomorrow include Green Planet Group Inc. (OTCBB: GNPG), Wellstar International Inc. (OTCBB: WLSI), IGSM Group Inc. (OTC: IGSM), XTend Medical Corp. (OTC: XMDC), Dynamic Response Group Inc. (OTCBB: DRGZ) and OriginOil Inc. (OTCBB: OOIL).

GREEN PLANET GROUP INCORPORATED (OTCBB: GNPG)

"Up 123.68% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/GNPG.php

Green Planet Group, Inc. is an emerging leader in environmentally safe products and services based in Scottsdale, Arizona. The Company engages in ongoing research and development to create products and services that enhance our environment. Revenues are currently derived from the production and distribution of fuel-based energy conservation and clean-air products, as well as through the placement of members of the growing ranks of the unemployed into meaningful “green collar” careers.

GNPG News:

October 26 - Green Planet Group Grows Revenues 3,000%

Green Planet Group, Inc. (OTCBB: GNPG) announced that its second quarter revenues increased to $16,230,000 which is just over a thirtyfold increase from the same period last year. Revenues for the first 6 months were $32.93 million versus $2.37 million from last year.

Edmond L. Lonergan, President/CEO of Green Planet Group, stated, “The exponential growth in our revenues has greatly strengthened all areas of our balance sheet as well as our cash flow and P&L performance. We believe that the continuation of this powerful trend will soon lead to sustainable profitability and the steady advancement of our products and Company in the exploding green marketplace.”

WELLSTAR INTERNATIONAL INCORPORATED (OTCBB: WLSI)

"Up 100.00% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/WLSI.php

Wellstar International, Inc., through its wholly owned operating subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body. More information on the Company and its unique diagnostic software and product line is available on Wellstar's corporate Website.

WLSI News:

October 14 - Wellstar International Announces Funding

Wellstar International, Inc. (OTCBB: WLSI) has announced that it has entered into a financing agreement with JMJ Financial to provide the Company with an expected $1.2 million dollars in operational funding over the eighteen months. Details of the financing were contained in the Company's Form 8-K filing with the Securities and Exchange Commission on October 9, 2009.

The initial funding has been transferred to Wellstar and is expected to continue on a monthly basis. This funding will allow Wellstar to continue to operate in the near future and develop the completion of its Trillennium Medical Imaging System for rollout to the medical community. Although we have entered into a definitive agreements with respect to the financing with JMJ Financial, we cannot provide any guarantee that the funding outlined in the agreements will continue on a monthly basis or at all.

Wellstar International, Inc. seeks to be the first-to-market in deep tissue injury and pressure ulcer detection using its proprietary infrared imaging system. Thermal Imaging is a low cost, noncontact, non-radioactive diagnostic screening procedure designed for clinical evaluation. In addition, thermal imaging provides an ability to track the progress of therapies being utilized in a low cost, non-invasive manner. Thermal Imaging can detect signs of pressure ulcers before they are visible with the naked eye through detection of temperature changes at the site which allows for treatment of the pressure ulcer before it erupts. The TMI system can be used to scan all new patients into hospitals and long-term care facilities prior admittance and begin treating existing wounds before they are visible.

IGSM GROUP INCORPORATED (OTC: IGSM)

"Up 31.03% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/IGSM.php

Based in Florida, IGSM Group Inc. recently announced its intention to become a full reporting company and operate Digital Television Channels in Florida. In addition, IGSM recently acquired a Television Library of Programs. IGSM also offers a suite of E-Learning products as part of its Digital Services.

IGSM News:

September 30 - IGSM Outlines Large-Scale Webinar Platform

IGSM Group Inc. (OTC: IGSM) outlines its large-scale webinar platform, the first of a series of E-Learning products.

IGSM Group Inc.outlined its Large-Scale webinar platform aimed at the corporate or repeat user who uses webinars on a regular basis. Whether they need 100, 500 or 1000 people on an interactive session IGSM can fulfill their needs.

"Our niche is to provide full service to the most demanding users. Whether they are corporate trainers or focused on end user education, they need a full service company," said H. Francis Fytton, CEO of IGSM. "Working closely with several content providers has enabled us to add the features they need and don't have from existing providers," added Fytton.

IGSM Group Inc.has previously announced that it will provide Distance Learning Solutions including TeleSeminars and Webinars. E-Learning or Distance Learning products have become more popular as corporations seek to reduce overhead by eliminating travel and meeting costs.

XTEND MEDICAL CORPORATION (OTC: XMDC)

"Up 92.73% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/XMDC.php 

XTend Medical is a company that specializes in the manufacturing and distribution of the latest in telemedicine and telehealth solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their continued efforts in identifying global companies with true product potential in the healthcare industry puts them in an advantageous position to capitalize on a global basis.

XMDC News:

October 22 - XTend Medical Updates Shareholders on Merger and Company's Progress

Management to Travel to Korea to Finalize Merger

XTend Medical Corp. (OTC: XMDC), a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the company's progress on merger and company's progress:

"XTend would like to update our shareholders on our progress to date. Mr. Lee from BioHarp, Korea traveled to Los Angeles last weekend to meet with the executives of XTend. The meetings were very positive and included several aspects in the manufacturing process and the business model moving forward. I personally want to thank Mr. Lee for his dedication and efforts in moving the merger forward. The management of XTend will be traveling to Korea soon to meet with the executives of BioHarp, Korea to finalize the merger. We also intend to secure the manufacturing relationships Mr. Lee has worked on over the past months in order to fulfill our needs for the BioHarp unit. Mr. Lee has identified several major manufacturers that can handle the volume of devices we'll need to fulfill the commitments we expect over the next 6-12 months and having strategic manufacturing partners in Korea to work closely with the technical staff is imperative to the success of the company. While in Korea, XTend management will also be looking to secure a listing on the Korean Stock Exchange that will add to our shareholder base on a global basis and gain additional exposure for the company.

The combined efforts of the seasoned technical team in Korea with the management in the U.S. will insure that the BioHarp device will become the standard in medical diagnosis. Our intention is to market the product aggressively throughout Asia, the U.S. and Europe. To date, we've had over 7 inquiries from medical device companies looking to represent the BioHarp in 4 different countries globally. As we move forward, these opportunities will be explored and if they benefit the company, we will press forward on a working relationship.

As to the BioHarp unit itself, I would like to reiterate a few areas that make this device unique:

1. The BioHarp requires a pre-scan of the patient in order to get a baseline reading. This baseline reading is not based solely on a set of standards in the medical sector. These individualized baselines are established from the patient's own cellular makeup and further solidify how the BioHarp sets itself apart from any present of future competitors.

2. The BioHarp device is completely portable. Unlike CT Scanners and other large pieces of equipment that remain stationary, the BioHarp can travel to where the patients are. The unit is perfect for rural areas, battlefields, or other outlying areas that would benefit by having the BioHarp as part of their healthcare service.

3. BioHarp can be used to detect cellular inflammation in plants. Diseases in crops have risen dramatically over the years and the BioHarp can assist scientists in helping to determine the proper course of treatment in order to insure plants can sustain life. The global percussion in this area can be tremendous for the company.

4. The dedication Mr. Lee has spent on this device over the past 14 years is truly incredible. His vision for this device has proven instrumental in the development of the BioHarp. His technical staff has, and continues t, spend countless hours perfecting this product and we feel honored to become part of this exciting and truly unique product.

In closing, I would like to thank all of our shareholders for being patient as we close this merger. Mr. Lee and I have worked continuously over the past two years to insure you, as shareholders, will reap the benefits of being part of something we're very proud of. The future is very bright for this company and through hard work and dedication, the BioHarp will flourish and become the leading diagnostic device in the global medical community," stated Mr. Paul D. Lisenby, CEO of XTend Medical.

DYNAMIC RESPONSE GROUP INCORPORATED (OTCBB: DRGZ)

"Up 30.00% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/DRGZ.php

Dynamic Response Group, Inc. is a marketing company, developer and distributor of personal development, wellness and entertainment consumer goods and services through print catalogs, radio, direct mail, direct response television programming (also known as DRTV or infomercials) and the Internet.

DRGZ News:

October 14 - Dynamic Response Group Rolls-Out National Campaign

Dynamic Response Group, Inc. (OTCBB: DRGZ) announced that, on October 19, 2009, it will start the national media campaign to roll-out its Medico Express diabetic supply products to the Hispanic market. The Company will begin airing television infomercials on Univision, Telefutura and Telemundo the three most watched Hispanic speaking stations. As the only company nationally addressing this niche, Dynamic Response Group (DRG) projects revenues from Medico to reach $13 million in 2010 more than tripling to $40 million by 2011.

"The national roll-out of Medico Express, DRG's diabetic product supply subsidiary and most recent venture into the Home Medical Equipment (HME) market, marks a tremendous growth opportunity for our Company," noted Melissa K. Rice, CEO. "The Hispanic population is the second-largest and fastest growing minority group in the United States and is now experiencing a dramatic increase in the incidence of diabetes. DRG's proven experience in the direct television industry has already created enormous income opportunities for our Company in this market."

The Hispanic market for diabetic products is estimated to be $748 million in the continental U.S. and is expected to surpass $1 billion in the next few years according to the Center for Disease Control. DRG's Medico Express offers the core products that are used regularly by diabetics. Studies show that Hispanics are almost twice as likely to develop diabetes as Caucasians of similar age which supports the fact that the Company's actual market test results far exceeded management's initial expectations.

ABOUT MEDICO EXPRESS, INC.

Medico Express now has the authority to sell its products in all 50 states. The Company recently received Medicare approval for Medico product reimbursement. Medico Express markets direct-to-consumer medical products designed to help treat Diabetes and other diseases. Medico's marketing strategy specifically targets Hispanic communities throughout the Continental U.S., Puerto Rico and the U.S. Virgin Islands. Medico Express, Inc. is a majority owned subsidiary of Dynamic Response Group, Inc.

ORIGINOIL INCORPORATED (OTCBB: OOIL)

"Up 26.67% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/OOIL.php 

OriginOil, Inc. is developing a breakthrough technology that will transform algae, the most promising source of renewable oil, into a true competitor to petroleum. Much of the world's oil and gas is made up of ancient algae deposits. Today, our technology will produce "new oil" from algae, through a cost-effective, high-speed manufacturing process. This endless supply of new oil can be used for many products, such as diesel, gasoline, jet fuel, plastics and solvents, without the global warming effects of petroleum. Other oil-producing feedstock, such as corn and sugarcane, often destroy vital farmlands and rainforests, disrupt global food supplies and create new environmental problems. Our unique technology, based on algae, is targeted at fundamentally changing our source of oil without disrupting the environment or food supplies.

OOIL News:

October 26 - OriginOil's Algae Oil Extraction Process Reaches Highest Industry Efficiency Standards

Research lab at California State University Long Beach collaborated on methodology

OriginOil, Inc. (OTCBB: OOIL), the developer of a breakthrough technology to transform algae, the most promising source of renewable oil, into a true competitor to petroleum, today announced that Single Step Extraction™, OriginOil's low energy process to extract oil from algae, has reached the highest industry standards for oil extraction efficiency.

In a long-running collaboration with an advanced research lab at California State University, Long Beach, OriginOil has optimized its Single Step Extraction process to reach the highest industry level for algae oil extraction. The typical efficiency for oil extraction is 94-97%. OriginOil's recent breakthrough can extract up to 97% of the oil from algae cells.

"This level of efficiency is astonishing for a process that requires less than a tenth of the energy of conventional processes, and without needing chemicals," said Riggs Eckelberry, OriginOil's CEO. "I congratulate our lead researcher, Dr. Dheeban Kannan, and the team at Cal-State Long Beach IIRMES for their achievement and very hard work."

"We have been working with OriginOil of Los Angeles for the past several months developing a method for lipid determination and we now feel that we have a very reliable method," said Richard Gossett, Director of the Institute for Integrated Research in Materials, Environments and Societies (IIRMES), an advanced research and analytical laboratory at California State University, Long Beach. "Using this method, we have tested OriginOil's Single-Step Extraction process with excellent results. With the optimization of this procedure, we look forward to welcoming other algae companies to use our laboratory."

A time-lapse video of OriginOil's Single Step Process is available at www.originoil.com, beginning with a batch of algae that has just gone through the process. In less than an hour, the oil, water and biomass separate by gravity alone. Unlike conventional systems, no chemicals or heavy machinery are used in this single-step process, and no initial dewatering is required.

OriginOil chief scientist Dr Vikram Pattarkine said, "With the performance efficiency of our process now validated, we can proceed with system level optimizations and pilot scale development with our commercial partners."

Harvesting algae is a challenge. Algae grows suspended in large volumes of water. Once ready for harvest, the algae culture must be concentrated and the oil extracted from each cell. Then, the oil, water and biomass must all be separated for processing. OriginOil's Single Step Extraction achieves all these steps in one pass.

In the process, the company's Quantum Fracturing™ technology combines with electromagnetic pulses and pH modification to break down cell walls, thereby releasing the oil within these cells. Algae oil rises to the top for skimming and refining, while the remaining biomass settles to the bottom for further processing as fuel and other valuable products.

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org/.

Disclosure: OTCPicks.com was once compensated three thousand dollars by a third party (Blue Wave Advisors) for a one-week OOIL advertising and promotional program and three thousand dollars by a third party (Blue Wave Advisors) for a previous promotional campaign.